Press release FDA approves ivabradine to treat patients with chronic heart failure

Cover Page

Cite item

Full Text

Abstract

Первый пероральный препарат для лечения хронической сердечной недостаточности, одобренный FDA за последние 10 лет

About the authors

- -

References


Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies